Q1 2025 DENTSPLY SIRONA Inc Earnings Call Transcript
Key Points
- Dentsply Sirona Inc (XRAY) delivered organic growth in two of its three global regions, exceeding expectations despite a 4.4% decline due to a negative 4% pipe impact.
- Imaging and Wellspect Healthcare segments showed strong performance, with growth across all regions driven by new product introductions and solid execution.
- The company achieved EBITDA margin expansion and EPS growth, reflecting transformational savings and improved operational efficiency.
- Dentsply Sirona Inc (XRAY) maintained its 2025 outlook for organic sales and adjusted EPS, with an increased outlook for reported sales due to favorable foreign currency translation changes.
- The DS Core ecosystem continues to gain traction, surpassing 42,000 unique users and processing over 100,000 lab orders each month, indicating strong adoption of digital dentistry solutions.
- The company faces headwinds from global trade tariffs, with an estimated $50 million annualized impact, which has been factored into the current guidance.
- Organic sales in the US declined by 14.9%, primarily due to a negative impact from Byte and declines in CAD/CAM and IPS segments.
- The Orthodontic and Implant Solutions segment experienced a significant organic sales decline of 17.7%, with a notable impact from the loss of a DSO customer in the US.
- Despite improvements, the company continues to face challenges in the US implant market, with a need to rebuild commercial team relationships and improve sales performance.
- Dentsply Sirona Inc (XRAY) is still in the process of searching for a permanent CFO, with the interim CFO having completed his assignment, which may impact financial leadership stability.
Welcome to the Q1 2025 Dentsply Sirona earnings conference call. (Operator Instructions) please be advised that today's conference is being recorded.
I would now like to hand the call over to Andrea Daley, Vice President of Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. Welcome to the Dentsply Sirona First Quarter 2025 Earnings Call. Joining me for today's call is Simon Campion, Chief Executive Officer; and Rich Rosensweig. Executive Vice President, Corporate Development and General Counsel.
I'd like to remind you that an earnings press release and slide presentation related to the call are available on the Investors section of our website at www.dentsplysirona.com. Before we begin, please take a moment to read the forward-looking statements in our earnings press release.
During today's call, we may make certain predictive statements that reflect our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
